[Determination of roxithromycin in serum by high-performance liquid chromatography with ultraviolet detection]. 2001

Y Qin, and Y Zou, and M Liang, and Y Huang, and Q Yu, and P Feng
Institute of Clinical Pharmacology, First Affiliated Hospital, WCUMS, Chengdu 610041, China.

OBJECTIVE To make better the RP-HPLC method for the determination of roxithromycin(RM) in human serum. METHODS RM and clarithromycin (internal standard) were extracted from alkalinized serum sample (500 microliters) with methylene chloride. After evaporation of the organic layer, the residue was dissolved in 100 microliters of acetonitrile-ammonium phosphate (1:1, pH 6.0) and washed with n-hexane, then 20 microliters was injected onto a column (5 microns, 15 cm x 4.6 mm) of Penomenex luna C18. The mobile phase was acetonitrile-0.05 mol/L phosphoric acid (39:19:42, adjusted to pH 7.2 with ammonia water) pumped at 1.2 ml/min through the column. The variable wavelength UV detector operated at 0.01 aufs and the wavelength was set at 210 nm. RESULTS The retention times for RM and clarithromycin were 4.4 min and 5.0 min, respectively. Standard curve was linear in the concentration range of 0.25 to 32 mg/L. The detection limit in serum was 0.06 mg/L; the average method recovery 97.4%; the inter-day RSD less than 3.0%. CONCLUSIONS This method was found to be simple, rapid, sensitive and accurate for determination of RM in human serum.

UI MeSH Term Description Entries
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014466 Ultraviolet Rays That portion of the electromagnetic spectrum immediately below the visible range and extending into the x-ray frequencies. The longer wavelengths (near-UV or biotic or vital rays) are necessary for the endogenous synthesis of vitamin D and are also called antirachitic rays; the shorter, ionizing wavelengths (far-UV or abiotic or extravital rays) are viricidal, bactericidal, mutagenic, and carcinogenic and are used as disinfectants. Actinic Rays,Black Light, Ultraviolet,UV Light,UV Radiation,Ultra-Violet Rays,Ultraviolet Light,Ultraviolet Radiation,Actinic Ray,Light, UV,Light, Ultraviolet,Radiation, UV,Radiation, Ultraviolet,Ray, Actinic,Ray, Ultra-Violet,Ray, Ultraviolet,Ultra Violet Rays,Ultra-Violet Ray,Ultraviolet Black Light,Ultraviolet Black Lights,Ultraviolet Radiations,Ultraviolet Ray
D015575 Roxithromycin Semisynthetic derivative of erythromycin. It is concentrated by human phagocytes and is bioactive intracellularly. While the drug is active against a wide spectrum of pathogens, it is particularly effective in the treatment of respiratory and genital tract infections. Biaxsig,Claramid,Infectoroxit,MTW-Roxithromycin,Macrosil,RU 28965,RU 965,RU-28965,RU-965,Rotesan,Rotramin,Roxi 1A Pharma,Roxi Basics,Roxi TAD,Roxi-Puren,Roxi-Q,Roxi-Wolff,Roxi-paed 1A Pharma,Roxi-saar,Roxibeta,Roxigamma,Roxigrün,Roxihexal,Roxithro-Lich,Rulid,Rulide,roxi von ct,roxidura,RU28965,RU965
D017291 Clarithromycin A semisynthetic macrolide antibiotic derived from ERYTHROMYCIN that is active against a variety of microorganisms. It can inhibit PROTEIN SYNTHESIS in BACTERIA by reversibly binding to the 50S ribosomal subunits. This inhibits the translocation of aminoacyl transfer-RNA and prevents peptide chain elongation. 6-O-Methylerythromycin,A-56268,Biaxin,TE-031,A 56268,A56268,TE 031,TE031

Related Publications

Y Qin, and Y Zou, and M Liang, and Y Huang, and Q Yu, and P Feng
September 1983, Journal of chromatography,
Y Qin, and Y Zou, and M Liang, and Y Huang, and Q Yu, and P Feng
May 1980, Journal of chromatography,
Y Qin, and Y Zou, and M Liang, and Y Huang, and Q Yu, and P Feng
October 1981, Journal of chromatography,
Y Qin, and Y Zou, and M Liang, and Y Huang, and Q Yu, and P Feng
February 1999, Journal of chromatography. B, Biomedical sciences and applications,
Y Qin, and Y Zou, and M Liang, and Y Huang, and Q Yu, and P Feng
January 1987, Biomedica biochimica acta,
Y Qin, and Y Zou, and M Liang, and Y Huang, and Q Yu, and P Feng
October 1985, Journal of pharmaceutical sciences,
Y Qin, and Y Zou, and M Liang, and Y Huang, and Q Yu, and P Feng
October 1988, Journal of chromatography,
Y Qin, and Y Zou, and M Liang, and Y Huang, and Q Yu, and P Feng
May 2017, Biomedical chromatography : BMC,
Y Qin, and Y Zou, and M Liang, and Y Huang, and Q Yu, and P Feng
September 1990, Journal of chromatography,
Y Qin, and Y Zou, and M Liang, and Y Huang, and Q Yu, and P Feng
December 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Copied contents to your clipboard!